Pro- and synbiotics to prevent sepsis in major surgery and severe emergencies

Area of Science:

• Microbiology
• Immunology
• Critical Care Medicine

Background:

• Sepsis leads to high morbidity and mortality, particularly following advanced medical treatments and acute emergencies.
• Modern medical interventions, including mechanical ventilation and synthetic drugs, compromise the human microbiota, impair immune function, and increase inflammation.
• Current attempts to restore gut microbiota for sepsis treatment have yielded inconsistent results.

Purpose of the Study:

• To investigate the potential of gut microbiota restoration as an alternative treatment for sepsis.
• To identify factors contributing to the failure of current probiotic interventions in sepsis management.

Main Methods:

• Review of existing literature on sepsis, medical treatments, and microbiota modulation.
• Analysis of factors influencing the efficacy of probiotic supplementation in sepsis.
• Exploration of the challenges in applying bio-ecological treatments as primary sepsis therapies.

Main Results:

• Advanced medical treatments significantly increase sepsis risk by disrupting the gut microbiota and immune system.
• Probiotic interventions often fail due to inappropriate species selection, inadequate dosage, and application as a complementary therapy.
• Lactic acid bacteria supplements are frequently ineffective due to premature degradation before reaching target organs.

Conclusions:

• The disruption of the human microbiota by modern medical practices is a significant contributor to sepsis morbidity.
• Current probiotic strategies for sepsis are limited by suboptimal application and formulation.
• Further research into alternative and primary bio-ecological treatments for sepsis is warranted to improve patient outcomes.